Literature DB >> 24460716

Enhancing ex vivo expansion of cord blood-derived unrestricted somatic stem cells for clinical applications.

Z Demerdash1, H El Baz, F Mahmoud, S Mohamed, K Maher, T Gaafar, S Shawky, M Hassan, D Abdelhady, T Taha.   

Abstract

OBJECTIVES: To study effects of serum-containing medium (SCM) versus serum-free medium (SFM) and influence of seeding density, on rate of expansion of cord blood (CB) unrestricted somatic stem cells (USSCs), as a prerequisite for evaluating their therapeutic potential in ongoing clinical trials.
MATERIAL AND METHODS: Isolation, propagation and characterization of USSCs from CB samples were performed and followed by their passage 3 culture in SCM and SFM, at cell densities of 5, 50, 500 and 5000 cells/cm(2) .
RESULTS: The cells were CD44(+) , CD90(+) , CD73(+) , CD105(+) , CD34(-) , CD45(-) , and HLA-DR, with Oct4 & Sox2 gene expression; they were differentiated into osteoblasts and adipocytes. USSCs cultured in SCM had significantly higher population doubling levels (P < 0.01) than those cultured in SFM. Those cultured in SCM at 5 cells/cm(2) and those cultured in SFM at 50 cells/cm(2) had significantly higher population doubling (P < 0.01) levels than those cultured at higher cell densities.
CONCLUSIONS: For scaling up of USSCs from 106 (?) to 1012 (?) in 6 weeks, culturing of CB-derived cells of early passage (≤P3) in SCM at low cell seeding density (5 cells/cm(2) ) is suggested for increasing cell count with lower passaging frequency, followed by culture of expanded USSCs at 50 cells/cm(2) in SFM, to avoid undesirable effects of bovine serum in clinical applications.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24460716      PMCID: PMC6496266          DOI: 10.1111/cpr.12070

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  35 in total

1.  Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord.

Authors:  Ingrida Majore; Pierre Moretti; Frank Stahl; Ralf Hass; Cornelia Kasper
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 2.  Stem cell transplantation as a therapeutic approach to organ failure.

Authors:  Ryan D Nagy; Ben M Tsai; Meijing Wang; Troy A Markel; John W Brown; Daniel R Meldrum
Journal:  J Surg Res       Date:  2005-07-19       Impact factor: 2.192

3.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

Review 4.  Application of mesenchymal stem cells in the regeneration of musculoskeletal tissues.

Authors:  E J Caterson; L J Nesti; T Albert; K Danielson; R Tuan
Journal:  MedGenMed       Date:  2001-02-05

5.  Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

Authors:  Olle Ringdén; Mehmet Uzunel; Ida Rasmusson; Mats Remberger; Berit Sundberg; Helena Lönnies; Hanns-Ulrich Marschall; Aldona Dlugosz; Attila Szakos; Zuzana Hassan; Brigitta Omazic; Johan Aschan; Lisbeth Barkholt; Katarina Le Blanc
Journal:  Transplantation       Date:  2006-05-27       Impact factor: 4.939

6.  Conditions to improve expansion of human mesenchymal stem cells based on rat samples.

Authors:  Maryam Ayatollahi; Maryam Kabir Salmani; Bita Geramizadeh; Seyed Ziaadin Tabei; Masoud Soleimani; Mohammad Hosein Sanati
Journal:  World J Stem Cells       Date:  2012-01-26       Impact factor: 5.326

7.  Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation.

Authors:  V J Cristofalo; R G Allen; R J Pignolo; B G Martin; J C Beck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.

Authors:  Panagiota A Sotiropoulou; Sonia A Perez; Maria Salagianni; Constantin N Baxevanis; Michael Papamichail
Journal:  Stem Cells       Date:  2005-08-18       Impact factor: 6.277

9.  Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells.

Authors:  Luis A Solchaga; Kitsie Penick; Victor M Goldberg; Arnold I Caplan; Jean F Welter
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

10.  Ex vivo expansion of human mesenchymal stem cells in defined serum-free media.

Authors:  Sunghoon Jung; Krishna M Panchalingam; Lawrence Rosenberg; Leo A Behie
Journal:  Stem Cells Int       Date:  2012-05-07       Impact factor: 5.443

View more
  2 in total

Review 1.  Placenta-based therapies for the treatment of epidermolysis bullosa.

Authors:  Christopher Nevala-Plagemann; Catherine Lee; Jakub Tolar
Journal:  Cytotherapy       Date:  2015-03-18       Impact factor: 5.414

2.  Use of Limiting Dilution Method for Isolation of Nucleus Pulposus Mesenchymal Stem/Progenitor Cells and Effects of Plating Density on Biological Characteristics and Plasticity.

Authors:  Linghan Lin; Zhiwei Jia; Yachao Zhao; Yaohong Wu; Xiyan Zhao; Yong Li; Ziming Guo; Jiahai Chen; Shi Cheng; Deli Wang; Dike Ruan
Journal:  Biomed Res Int       Date:  2017-10-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.